NHS National Framework for Lenvatinib

Buyer
NHS England
Value
£35,833,000
Closes
30 October 2026
Where
London, the North East
Type
Sets up a framework (suppliers apply to join)

In plain English

NHS England is buying the cancer drug Lenvatinib for different regions of England. This is a pharmaceutical supply contract, not a construction or trades contract. Suppliers must be licensed pharmaceutical wholesalers or manufacturers able to distribute this specific medicine to NHS trusts.

What the buyer wants

• Supply Lenvatinib (a prescription cancer medication) to NHS England regions (CESW, NWLN, LSNE) for the specified contract periods • Maintain pharmaceutical distribution licenses and comply with all medicines regulations and cold chain requirements • Provide invoicing, stock management, and delivery services to NHS trusts across assigned regions

Likely requirements

Our reading of the notice. Always check the tender documents.

This contract is exclusively for licensed pharmaceutical wholesalers and manufacturers. No small construction, trades, cleaning, or general business can bid: you must hold active MHRA pharmaceutical distribution licenses and be a regulated medicines supplier.

How to bid

This is a framework: the buyer picks a set of suppliers now and awards work to them over several years. If you are not on it when it is awarded, you usually cannot win work from it until it is re-tendered, so this is the window to bid.

How framework contracts work

More open tenders from NHS England

Similar open health and social care contracts

Check whether your business could win this, free

Get a plain-English bid plan for this tender with the bid coach

More health and social care contracts in the North East